{"url_path":"/sec/mtne/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/2044817/0001193125-26-269963-index.html","accession_number":"0001193125-26-269963","cik":"0002044817","ticker":"MTNE","issuer_name":"CH4 Natural Solutions Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/2044817/0001193125-26-269963-index.html","primary_entity_key":"0002044817","primary_entity_name":"CH4 Natural Solutions Corp"},"word_count":776,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\n \n\nExhibit\nNumber\n\n  \n\nDescription of Exhibit\n\n1.1\n  \n[Underwriting Agreement, dated April 30, 2026, between the Company and Santander US Capital Markets LLC (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex11.htm)\n\n3.1\n  \n[Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex31.htm)\n\n4.1\n  \n[Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1 (Commission File No. 333- 284199), filed April 24, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526174250/d872695dex41.htm)\n\n4.2\n  \n[Specimen Class A Ordinary Shares Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 (Commission File No. 333- 284199), filed April 24, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526174250/d872695dex42.htm)\n\n4.3\n  \n[Specimen Public Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-1 (Commission File No. 333- 284199), filed April 24, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526174250/d872695dex43.htm)\n\n4.4\n  \n[Specimen Private Warrant Certificate (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-1 (Commission File No. 333- 284199), filed April 24, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526174250/d872695dex44.htm)\n\n4.5\n  \n[Private Warrant Agreement, dated April 30, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex41.htm)\n\n4.6\n  \n[Public Warrant Agreement, dated April 30, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex42.htm)\n\n10.1\n  \n[Letter Agreement, dated April 30, 2026, among the Company, its officers and directors, the Sponsor and the Security Holdings Sponsor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex101.htm)\n\n10.2\n  \n[Investment Management Trust Agreement, dated April 30, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex102.htm)\n\n10.3\n  \n[Registration Rights Agreement, dated April 30, 2026, among the Company, the Sponsor and the Security Holdings Sponsor (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex103.htm)\n\n10.4\n  \n[Administrative Support Agreement, dated April 30, 2026, between the Company and an affiliate of the Sponsor (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex104.htm)\n\n10.5\n  \n[Private Placement Units Purchase Agreement, dated April 30, 2026, between the Company and the Security Holdings Sponsor (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764dex105.htm)\n\n10.6\n  \n[Form of Indemnification Agreement (incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form S-1 (Commission File No. 333- 284199), filed April 24, 2026).](http://www.sec.gov/Archives/edgar/data/2044817/000119312526174250/d872695dex108.htm)\n\n10.7*\n  \n[Second Amended and Restated Promissory Note, dated June 12, 2026, between the Company and an affiliate of the Sponsor.](d58871dex107.htm)\n\n \n\n22\n\n##### Table of Contents\n\n31.1*\n  \n[Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](d58871dex311.htm)\n\n31.2*\n  \n[Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](d58871dex312.htm)\n\n32.1**\n  \n[Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](d58871dex321.htm)\n\n32.2**\n  \n[Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](d58871dex322.htm)\n\n101*\n  \nInteractive Data Files (filed herewith as Exhibit 101).\n\n104*\n  \nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\n\nFiled herewith\n\n**\n\nThese certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Exchange Act, nor shall they be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.\n\n \n\n23\n\n##### Table of Contents\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \nCH4 NATURAL SOLUTIONS CORPORATION\n\nDate: June 12, 2026\n \n\n \nBy:\n \n\n/s/ Arthuros Mangriotis\n\n \n\n \nName:\n \nArthuros Mangriotis\n\n \n\n \nTitle:\n \nChief Financial Officer, Chief Accounting Officer and Secretary\n\n \n\n24"}